The respective N-hydroxypyrazole analogues of the classical glutamate receptor ligands ibotenic acid and (RS)-2-amino-2-(3-hydroxy-5-methyl-4-isoxazolyl)acetic acid

European Journal of Pharmacology
Rasmus P ClausenHans Bräuner-Osborne

Abstract

We have determined the pharmacological activity of N-hydroxypyrazole analogues (3a and 4a) of the classical glutamate receptor ligands ibotenic acid and (RS)-2-amino-2-(3-hydroxy-5-methyl-4-isoxazolyl)acetic acid (AMAA), as well as substituted derivatives of these two compounds. The pharmacological profile of 3a is closer to that of thioibotenic acid rather than ibotenic acid, while 4a is a selective N-methyl-D-aspartic acid (NMDA) receptor agonist. Ring substitution of 3a and 4a leads to NMDA receptor antagonists. Whereas efficacy of 3a derivatives at mglu2 receptor decreases from agonism via partial agonism to antagonism with increasing substituent size, substitution abolishes affinity for mglu1 and mglu4 receptors. Ligand- and receptor-based modelling approaches assist in explaining these pharmacological trends among the metabotropic receptors and suggest a mechanism of partial agonism at mglu2 receptor similar to that proposed for the GluR2 glutamate receptor.

References

Jan 1, 1992·Neuron·Y TanabeS Nakanishi
Feb 28, 1985·Neuroscience Letters·T Honoré, M Nielsen
Aug 2, 1996·Journal of Medicinal Chemistry·H Bräuner-OsborneP Krogsgaard-Larsen
Jan 1, 1997·Annual Review of Pharmacology and Toxicology·P J Conn, J P Pin
Jul 14, 2000·Journal of Medicinal Chemistry·H Bräuner-OsborneP Krogsgaard-Larsen
Dec 18, 2001·The Journal of Biological Chemistry·Erica RosemondDavid R Hampson
Jan 5, 2002·Journal of Medicinal Chemistry·Tine B StensbølPer Vedsø
Aug 2, 2002·Proceedings of the National Academy of Sciences of the United States of America·Anne-Sophie BessisJean-Philippe Pin
Feb 27, 2004·European Journal of Pharmacology·Mette B HermitHans Bräuner-Osborne

❮ Previous
Next ❯

Citations

Mar 10, 2007·European Journal of Medicinal Chemistry·Paola ContiCarlo De Micheli
Mar 8, 2007·Organic & Biomolecular Chemistry·Charlotte G JørgensenUlf Madsen
Oct 15, 2010·Chemistry : a European Journal·Rune RisgaardRasmus P Clausen
Sep 1, 2005·Molecular Pharmacology·Kasper B HansenHans Bräuner-Osborne
Jun 27, 2008·Journal of Medicinal Chemistry·Rasmus P ClausenJesper L Kristensen

❮ Previous
Next ❯

Related Concepts

Related Feeds

Aminoglycosides (ASM)

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Aminoglycosides

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.